Immunological results from a study with Diamyd® will be presented in April
Diamyd Medical (Nasdaq Stockholm First North Ticker: DMYD B) informs that immunological results from DIABGAD, one of five ongoing studies with the diabetes vaccine Diamyd®, will be presented at an international diabetes congress (IDS) held in Munich on April 12 to 16, 2015.Immunological findings from a study with Diamyd®, DIABGAD, will be presented by Professor Johnny Ludvigsson at an international diabetes meeting held in Munich on April 12-16, 2015. Preparations for the code break are ongoing and the code will be broken and the results analyzed shortly before the presentation. In the